4//SEC Filing
Sullivan Lara 4
Accession 0001209191-23-049826
CIK 0001782223other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 7:03 PM ET
Size
6.1 KB
Accession
0001209191-23-049826
Insider Transaction Report
Form 4
Sullivan Lara
DirectorPresident ,CEO & CMO
Transactions
- Sale
Common Stock
2023-09-14$2.25/sh−100$225→ 2,412,423 total - Sale
Common Stock
2023-09-18$2.10/sh−8,541$17,936→ 2,403,882 total
Documents
Issuer
Pyxis Oncology, Inc.
CIK 0001782223
Entity typeother
Related Parties
1- filerCIK 0001769457
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 7:03 PM ET
- Size
- 6.1 KB